Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 6 (of 6 Records)

Query Trace: Pancreatic Neoplasms and RRM1[original query]
Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Jan 16 (1): 320-9.
Okazaki Taro, Javle Milind, Tanaka Motofumi, Abbruzzese James L, Li Dongh
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.
Cancer 2010 Nov 116 (22): 5325-35.
Tanaka Motofumi, Javle Milind, Dong Xiaoqun, Eng Cathy, Abbruzzese James L, Li Dongh
Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer.
Pancreas 2011 Jul 40 (5): 657-63.
Zeng Hongmei, Yu Herbert, Lu Lingeng, Jain Dhanpat, Kidd Mark S, Saif M Wasif, Chanock Stephen J, Hartge Patricia, , Risch Harvey
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.
Investigational new drugs 2012 Jun 30 (3): 1164-74.
Oh Do-Youn, Lee Keun Wook, Lee Kyung-Hee, Sohn Chang-Hak, Park Young Suk, Zang Dae Young, Ryoo Hun-Mo, Song Hong-Suk, Kim Jin-Soo, Kang Hye-Jin, Kim Bong-Seog, Bang Yung-J
Prediction of a side effect and efficacy of adjuvant chemotherapy with gemcitabine for post operative patient of pancreatic cancer by a genetic polymorphism analysis.
Hepato-gastroenterology 0 59 (117): 1609-13.
Kasuya Kazuhiko, Tsuchida Akihiko, Nagakawa Yuichi, Suzuki Yoshiaki, Suzuki Minako, Aoki Tatsuya, Abe Yuta, Shimazu Motohide, Itoi Takao, Sofuni Atsus
6:2 Cl-PFESA, a proposed safe alternative for PFOS, diminishes the gemcitabine effectiveness in the treatment of pancreatic cancer.
Journal of hazardous materials 2024 6 474 134790.
Jiawei Hong, Keyi Du, Weichen Zhang, Junran Chen, Hangbiao Jin, Yuanchen Chen, Yifan Jiang, Hanxi Yu, Xiaoyu Weng, Shusen Zheng, Jun Yu, Linping C
TOP